GLENDALE, Calif., March 16, 2018 -- Leading the charge to disrupt the multi-billion dollar medical record retrieval and review industry, Health Data Vision, Inc. (HDVI) today announced the migration of their core infrastructure for their enterprise-class SaaS platform, MRCS 4.3, to Amazon Web Services (AWS), in partnership with Datapipe, a Rackspace Company.
HDVI is excited to leverage the AWS environment to expand its offerings in the government-sponsored health plan marketplace. HDVI’s mission is to securely collect and code/abstract medical records on behalf of health insurance issuers, for Quality Improvement and Risk Adjustment initiatives. HDVI’s migration to AWS allows new technologies, services and capabilities to be deployed quickly for its MRCS platform, along with military-grade encryption.
MRCS's transition to AWS began after an extensive search of managed service providers (MSPs), such as Datapipe, who are providing the same innovation in their field as Health Data Vision is achieving in the healthcare space. Datapipe’s model is well suited for HDVI, as a rapidly-growing player in healthcare technology, by bringing to the table enhanced scalability of its computing needs inside of AWS's highly secure environment.
"HDVI’s collaboration with Datapipe and AWS will allow us to accelerate our pace of innovation, while providing peace of mind that our solutions are secure and scalable," said Jay Ackerman, CEO of HDVI. "We are proud to partner with Datapipe to help us navigate the ever-changing world of the cloud, development operations, and security."
About Health Data Vision, Inc.
Health Data Vision, Inc., a leader in the medical record retrieval and review (MRR) industry serving customers across the U.S., empowers health plans to take control of their Quality / HEDIS® and Risk Adjustment initiatives to improve quality of care and revenue performance. With its licensable MRCS SaaS platform and proprietary Secure Virtual Print that supports paperless electronic medical record collection, customers and partners can manage projects with either full-service or in-house resources, or by using a collaborative model. Learn more at healthdatavision.com or call (866) 969-3222.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs 



